These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35405115)

  • 41. Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function.
    Conlon K; Christy C; Westbrook S; Whitlock G; Roberts L; Stobie A; McMurray G
    J Pharmacol Exp Ther; 2009 Sep; 330(3):892-901. PubMed ID: 19498105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.
    Pytka K; Lustyk K; Żmudzka E; Kotańska M; Siwek A; Zygmunt M; Dziedziczak A; Śniecikowska J; Olczyk A; Gałuszka A; Śmieja J; Waszkielewicz AM; Marona H; Filipek B; Sapa J; Mogilski S
    Front Pharmacol; 2016; 7():229. PubMed ID: 27536240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. History and nomenclature of alpha1-adrenoceptors.
    Langer SZ
    Eur Urol; 1999; 36 Suppl 1():2-6. PubMed ID: 10438241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity.
    Savontaus E; Raasmaja A; Rouru J; Koulu M; Pesonen U; Virtanen R; Savola JM; Huupponen R
    Eur J Pharmacol; 1997 Jun; 328(2-3):207-15. PubMed ID: 9218703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A).
    Corboz MR; Rivelli MA; McCormick KD; Wan Y; Shah H; Umland S; Lieber G; Jia Y; McLeod RL; Morgan C; Varty GB; Wu J; Feng KI; Boyce CW; Aslanian RG; Palamanda J; Nomeir AA; Korfmacher W; Hunter JC; Anthes JC; Hey JA
    J Pharmacol Exp Ther; 2011 Apr; 337(1):256-66. PubMed ID: 21233198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protean agonism at alpha2A-adrenoceptors.
    Jansson CC; Kukkonen JP; Näsman J; Huifang G; Wurster S; Virtanen R; Savola JM; Cockcroft V; Akerman KE
    Mol Pharmacol; 1998 May; 53(5):963-8. PubMed ID: 9584224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro.
    Ibarra M; Hong E; Villalobos-Molina R
    J Auton Pharmacol; 2000 Jun; 20(3):139-45. PubMed ID: 11193002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat.
    Docherty JR
    Eur J Pharmacol; 2012 Mar; 679(1-3):90-4. PubMed ID: 22290390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.
    Uhlén S; Dambrova M; Näsman J; Schiöth HB; Gu Y; Wikberg-Matsson A; Wikberg JE
    Eur J Pharmacol; 1998 Feb; 343(1):93-101. PubMed ID: 9551719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible role of alpha-adrenoceptor subtypes in acute migraine therapy.
    Willems EW; Valdivia LF; Villalón CM; Saxena PR
    Cephalalgia; 2003 May; 23(4):245-57. PubMed ID: 12716341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic diabetes and hypertension impair the in vivo functional response to phenylephrine independent of α
    Rodríguez JE; Ruiz-Hernández A; Hernández-DíazCouder A; Huang F; Hong E; Villafaña S
    Eur J Pharmacol; 2020 Sep; 883():173283. PubMed ID: 32619676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α
    Ishida H; Saito SY; Ishikawa T
    Eur J Pharmacol; 2018 Nov; 838():120-128. PubMed ID: 30194940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception.
    Kingery WS; Agashe GS; Guo TZ; Sawamura S; Davies MF; Clark JD; Kobilka BK; Maze M
    Anesthesiology; 2002 Feb; 96(2):367-74. PubMed ID: 11818770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of alpha-2 adrenoceptor subtype in the antiallodynic effect of intraplantar dexmedetomidine in a rat spinal nerve ligation model.
    Lee HG; Choi JI; Kim YO; Yoon MH
    Neurosci Lett; 2013 Dec; 557 Pt B():118-22. PubMed ID: 24161890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of alpha1 -adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis.
    Takakura K; Taniguchi T; Muramatsu I; Takeuchi K; Fukuda S
    Crit Care Med; 2002 Apr; 30(4):894-9. PubMed ID: 11940765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies.
    Yang M; Reese J; Cotecchia S; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):841-7. PubMed ID: 9694940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.
    Scheibner J; Trendelenburg AU; Hein L; Starke K
    Br J Pharmacol; 2001 Feb; 132(4):925-33. PubMed ID: 11181434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in ultraviolet B light-induced erythema by oxymetazoline and brimonidine is mediated by different α-adrenoceptors.
    Hsia E; Tian M; Gil D
    Exp Dermatol; 2018 Jul; 27(7):763-768. PubMed ID: 29637626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The antipsychotic drug sertindole is a specific inhibitor of alpha1A-adrenoceptors in rat mesenteric small arteries.
    Ipsen M; Zhang Y; Dragsted N; Han C; Mulvany MJ
    Eur J Pharmacol; 1997 Oct; 336(1):29-35. PubMed ID: 9384251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deletion of the α2A/α2C-adrenoceptors accelerates cutaneous wound healing in mice.
    Romana-Souza B; Nascimento AP; Brum PC; Monte-Alto-Costa A
    Int J Exp Pathol; 2014 Oct; 95(5):330-41. PubMed ID: 25186490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.